Non-Small Cell Lung Cancer
A Randomized Phase III Double Blind Trial Evaluating Selective Cox-2 Inhibition in Cox-2 Expressing Advanced Non-Small Cell Lung Cancer.
For additional information please contact Nurdan IIgaz, Clinical Research Coordinator, at 859-260-6406.
REF# CBH 11-985
Phase 1b/2, Multicenter, Open-label Study of Carfilzomib, Carboplatin, and Etoposide in Subjects with Previously Untreated Extensive Stage Small-cell Lung Cancer.
For additional information please contact Heather Tudor, Clinical Research Coordinator, at 859-260-3196.